EMPRESSION
Live / Registered — Registered (as of 30 Nov 2021)
What this means for you
Registered since 30 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90043769
- Registration number
- 6577540
- Mark type
- Stylized text
- Filed
- 09 Jul 2020
- Published for opposition
- 24 Nov 2020
- Registered
- 30 Nov 2021
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products
Owner
- Empress Therapeutics, Inc., Cambridge, MA, US
- Empress Therapeutics, Inc., Cambridge, MA, US
- Empress Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 26 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Oct 2021 — ASSIGNED TO EXAMINER
- 28 Aug 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Aug 2021 — USE AMENDMENT FILED
- 28 Aug 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Aug 2021 — TEAS STATEMENT OF USE RECEIVED
- 21 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jul 2021 — SOU EXTENSION 1 GRANTED
- 19 Jul 2021 — SOU EXTENSION 1 FILED
- 19 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Nov 2020 — PUBLISHED FOR OPPOSITION